80 related articles for article (PubMed ID: 2373674)
1. Myeloid antigen expression in adult acute lymphoblastic leukemia: clinicohematological correlations and prognostic relevance.
Ferrara F; De Rosa C; Fasanaro A; Mele G; Finizio O; Schiavone EM; Spada OA; Rametta V; Del Vecchio L
Hematol Pathol; 1990; 4(2):93-8. PubMed ID: 2373674
[TBL] [Abstract][Full Text] [Related]
2. Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen.
Davey FR; Mick R; Nelson DA; MacCallum J; Sobol RE; Royston I; Cuttner J; Ellison RR; Bloomfield CD
Leukemia; 1988 Jul; 2(7):420-6. PubMed ID: 3164798
[TBL] [Abstract][Full Text] [Related]
3. Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.
Drexler HG; Thiel E; Ludwig WD
Leukemia; 1991 Aug; 5(8):637-45. PubMed ID: 1886419
[TBL] [Abstract][Full Text] [Related]
4. [The induction of differentiation of myeloid antigen positive acute lymphoblastic leukemia by phorbol ester (TPA) or GM-CSF].
Takeuchi H; Katayama I
Rinsho Ketsueki; 1990 May; 31(5):639-46. PubMed ID: 2203920
[TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
6. Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.
Boldt DH; Kopecky KJ; Head D; Gehly G; Radich JP; Appelbaum FR
Leukemia; 1994 Dec; 8(12):2118-26. PubMed ID: 7807999
[TBL] [Abstract][Full Text] [Related]
7. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
Schlesinger M; Silverman LR; Jiang JD; Yagi MJ; Holland JF; Bekesi JG
J Clin Lab Immunol; 1996; 48(4):149-66. PubMed ID: 9819667
[TBL] [Abstract][Full Text] [Related]
8. [MIC categorization of acute lymphoblastic leukemia with myeloid surface antigen expression].
Wu WL; Liang JY; Zhu MQ; Xue YQ; Chen ZX
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):754-6. PubMed ID: 18457267
[TBL] [Abstract][Full Text] [Related]
9. Relation of some cytochemical activities to the expression of CD34 marker in acute leukemia.
Klobusická M; Babusíková O; Hrivnáková A
Neoplasma; 1993; 40(5):309-14. PubMed ID: 7505888
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
[TBL] [Abstract][Full Text] [Related]
11. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance.
Lauria F; Raspadori D; Ventura MA; Rondelli D; Testoni N; Tosi P; Michieli M; Damiani D; Motta MR; Tura S
Stem Cells; 1995 Jul; 13(4):428-34. PubMed ID: 7549902
[TBL] [Abstract][Full Text] [Related]
12. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of standard CD assessment in acute leukemia.
Tupitsyn NN; Babusíková O; Baryshnikov AYu ; Ujházy P; Kadagidze ZG; Mahonova LA; Peterson IS; Protasova AK; Drozdova TS; Artemjev AK
Neoplasma; 1990; 37(4):431-8. PubMed ID: 2146517
[TBL] [Abstract][Full Text] [Related]
14. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia.
Sobol RE; Mick R; Royston I; Davey FR; Ellison RR; Newman R; Cuttner J; Griffin JD; Collins H; Nelson DA
N Engl J Med; 1987 Apr; 316(18):1111-7. PubMed ID: 3494942
[TBL] [Abstract][Full Text] [Related]
15. Functional and phenotypic upregulation of CD13/aminopeptidase-N on precursor-B acute lymphoblastic leukemia after in vitro stimulation.
Makrynikola V; Favaloro EJ; Browning T; Bianchi A; Bradstock KF
Exp Hematol; 1995 Oct; 23(11):1173-9. PubMed ID: 7556527
[TBL] [Abstract][Full Text] [Related]
16. A subset of acute lymphoblastic leukemia with co-expression of myeloid antigens: prevalence and clinical significance.
Hsu PN; Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH; Liang DC; Lin KS
J Formos Med Assoc; 1991 Mar; 90(3):225-31. PubMed ID: 1677396
[TBL] [Abstract][Full Text] [Related]
17. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
[TBL] [Abstract][Full Text] [Related]
18. Lymphoblastic transformation of chronic myelomonocytic leukemia in an infant.
Yamamoto M; Nakagawa M; Ichimura N; Ohtsuki F; Ohtsuka Y; Tsujino Y; Tanaka A; Kamiya T; Wada H
Am J Hematol; 1996 Jul; 52(3):212-4. PubMed ID: 8756090
[TBL] [Abstract][Full Text] [Related]
19. Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study.
Yenerel MN; Atamer T; Yavuz AS; Kucukkaya R; Besisik S; Aktan M; Keskin H; Nalcaci M; Sargin D; Pekcelen Y; Dincol G
Ann Hematol; 2002 Sep; 81(9):498-503. PubMed ID: 12373349
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
Ribera JM; Ortega JJ; Oriol A; Granada I; Hernández-Rivas JM; Parody R; Bethencourt C; Rivas C; Bastida P; del Potro E; González-Valentín ME; Moreno MJ; Besalduch J; Fernández-Calvo J; Tormo M; Arias J; Molinés A; Sanz MA; Maldonado J; Millá F; Feliu E; San Miguel JF;
Haematologica; 2002 Feb; 87(2):154-66. PubMed ID: 11836166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]